CD8A and neoplasm: Interestingly in non‐pCR patients, the levels of tumor‐infiltrating CD8+ and PD1+CD8+ cells, as well as the PD1+CD8+/CD8+ ratio, increased after NAT, while the percentage of PD1+ cells significantly decreased.